Ixabepilone Administered as an Enteric Coated Formulation.
The purpose of this study is to determine the pharmacokinetics of oral Ixabepilone.
Cancer
DRUG: Ixabepilone|DRUG: Ixabepilone|DRUG: Ixabepilone
Determine the action of Ixabepilone in the body over a period of time including the process of absorption, distribution, metabolism and elimination.
Determine the rate and extent to which Ixabepilone is absorbed or otherwise available to the treatment site in the body.
The purpose of this study is to determine the pharmacokinetics of oral Ixabepilone.